These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36327996)

  • 41. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
    Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
    Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.
    Pacheco-Lugo L; Sáenz-García J; Navarro Quiroz E; González Torres H; Fang L; Díaz-Olmos Y; Garavito de Egea G; Egea Bermejo E; Aroca Martínez G
    Lupus; 2019 Jan; 28(1):34-43. PubMed ID: 30453818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biopsy proven lupus nephritis in a black male patient in West Africa with systemic lupus erythematosus: case report.
    Tannor EK; Yeboah-Mensah K
    Pan Afr Med J; 2018; 31():198. PubMed ID: 31065329
    [No Abstract]   [Full Text] [Related]  

  • 48. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
    Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
    Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
    Qi L; Xu J; Yang C; Hou X; Yang P
    Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of non-coding RNA in lupus nephritis.
    Liang H; Liu Q
    Hum Cell; 2023 May; 36(3):923-936. PubMed ID: 36840837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
    Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
    Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis.
    Urrego-Callejas T; Álvarez SS; Arias LF; Reyes BO; Vanegas-García AL; González LA; Muñoz-Vahos CH; Vásquez G; Quintana LF; Gómez-Puerta JA
    Clin Rheumatol; 2021 May; 40(5):1853-1859. PubMed ID: 33079302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
    Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of circulating miR-148a and miR-126 with autoantibodies as biomarkers of lupus nephritis in patients with SLE.
    Omidi F; Khoshmirsafa M; Kianmehr N; Faraji F; Delbandi A; Seif F; Shekarabi M
    J Immunoassay Immunochem; 2022 Nov; 43(6):634-647. PubMed ID: 35938736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus.
    He J; Ma C; Tang D; Zhong S; Yuan X; Zheng F; Zeng Z; Chen Y; Liu D; Hong X; Dai W; Yin L; Dai Y
    Front Immunol; 2022; 13():964901. PubMed ID: 36275708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistin as a potential marker of renal disease in lupus nephritis.
    Hutcheson J; Ye Y; Han J; Arriens C; Saxena R; Li QZ; Mohan C; Wu T
    Clin Exp Immunol; 2015 Mar; 179(3):435-43. PubMed ID: 25345756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the relationship between urinary level of uromodulin, renal involvement and disease activity in patients with systemic lupus erythrematosus.
    Bedair RN; Amin Ismail MM; Gaber EW; Kader Mahmoud RA; Mowafy MN
    Saudi J Kidney Dis Transpl; 2020; 31(1):32-43. PubMed ID: 32129195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Something new about prognostic factors for lupus nephritis? A systematic review.
    Rodríguez-Almaraz E; Gutiérrez-Solís E; Rabadán E; Rodríguez P; Carmona L; Morales E; Galindo M
    Lupus; 2021 Dec; 30(14):2256-2267. PubMed ID: 34907831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Lupus Nephritis: An Update.
    Gupta KL; Bharati J
    J Assoc Physicians India; 2022 Mar; 70(3):11-12. PubMed ID: 35438287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.